Stockscreener 앱 받기
1.99
2.31%
0.045
전일 마감가:
$1.945
열려 있는:
$1.99
하루 거래량:
41,917
Relative Volume:
0.59
시가총액:
$3.53M
수익:
$770.00K
순이익/손실:
$-38.84M
주가수익비율:
-0.1401
EPS:
-14.2049
순현금흐름:
$-43.02M
1주 성능:
-47.17%
1개월 성능:
-48.45%
6개월 성능:
-76.67%
1년 성능:
-78.73%
1일 변동 폭
$1.89
$2.016
1주일 범위
$1.63
$2.27
52주 변동 폭
$1.63
$37.50
Lyra Therapeutics Inc Stock (LYRA) Company Profile
명칭
Lyra Therapeutics Inc
전화
617-373-4600
주소
480 ARSENAL WAY, WATERTOWN, MA
LYRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LYRA
Lyra Therapeutics Inc
|
1.99 | 3.45M | 770.00K | -38.84M | -43.02M | -14.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-07 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-05-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-05-07 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-05-06 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-10-06 | 재개 | BTIG Research | Buy |
| 2023-08-31 | 개시 | H.C. Wainwright | Buy |
| 2022-05-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-05-26 | 개시 | BTIG Research | Buy |
| 2020-05-26 | 개시 | BofA/Merrill | Buy |
| 2020-05-26 | 개시 | Jefferies | Buy |
| 2020-05-26 | 개시 | William Blair | Outperform |
모두보기
Lyra Therapeutics Inc 주식(LYRA)의 최신 뉴스
Weekly Buzz: LYRA Slashes Jobs; FDA Okays FBIO's ZYCUBO; BSX To Acquire PEN; BCTX On Watch - RTTNews
Aug Spikes: Is Lyra Therapeutics Inc stock a good pick for beginnersJuly 2025 Recap & Consistent Return Strategy Ideas - baoquankhu1.vn
Bearish Setup: Will Cheniere Energy Inc stock hit new highs in YEARWeekly Loss Report & Safe Entry Point Identification - baoquankhu1.vn
Layoff Tracker: Lyra Shutters, EMD Serono Downsizes - BioSpace
Will Lyra Therapeutics Inc be affected by tariffsJuly 2025 Setups & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
EV Market: Will Lyra Therapeutics Inc stock maintain momentum in 2025Analyst Downgrade & Weekly Return Optimization Plans - Bộ Nội Vụ
Lyra Therapeutics suspends further development of LYR-210 - Yahoo Finance
Lyra Therapeutics halts development of lead CRS treatment By Investing.com - Investing.com Nigeria
Mass. biotech company lays off entire workforce as cash dwindles - NBC Boston
Gold Rises Sharply; Lyra Therapeutics Shares Plunge - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Watertown biotech suspends drug development and eliminates workforce as cash dwindles - The Business Journals
LYRA Plunges 55% After Company Halts Lead Program And Begins Strategic Review - Nasdaq
Why Is Lyra Therapeutics Stock (LYRA) Down Today? - TipRanks
Lyra Therapeutics plunges after halting development of lead nasal drug - TradingView — Track All Markets
Lyra Therapeutics Inc terminates CEO Maria Palasis and CFO Jason CavalierSEC filing - marketscreener.com
Lyra Therapeutics halts development of lead CRS treatment - Investing.com
Lyra Therapeutics Provides Corporate Update - The Manila Times
Sinus drug work halted at Lyra Therapeutics as most of 28 staff exit roles - Stock Titan
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Lags Revenue Estimates - sharewise.com
How Lyra Therapeutics Inc. stock reacts to Fed rate cutsWeekly Profit Report & Free Reliable Trade Execution Plans - Улправда
Is Lyra Therapeutics Inc. stock attractive after correctionJuly 2025 Fed Impact & Verified Entry Point Signals - Улправда
Can Lyra Therapeutics Inc. stock attract ESG capital inflowsWeekly Trade Review & Daily Profit Maximizing Trade Tips - Улправда
Published on: 2026-01-08 23:57:46 - Улправда
What momentum indicators show for Lyra Therapeutics Inc. stock2025 Support & Resistance & Free High Accuracy Swing Entry Alerts - ulpravda.ru
ulpravda> 2026> How CHCT stock benefits from tech adoptionRecession Risk & Trade Opportunity Analysis Reports - ulpravda.ru
Is Lyra Therapeutics Inc. stock attractive for income investors2025 Technical Patterns & Weekly Breakout Stock Alerts - Улправда
Can Lyra Therapeutics Inc. stock sustain revenue growthSwing Trading Ideas & Our Picks = Your Future Gains - Улправда
Breakouts Watch: How supply chain issues affect Lyra Therapeutics Inc stockWeekly Investment Recap & Real-Time Stock Entry Alerts - Bộ Nội Vụ
Would You Accumulate or Wait on Hoac Foods India Limited (HOACFOODS)Earnings Miss Alerts & Small Investment Growth Tips - bollywoodhelpline.com
Will Lyra Therapeutics Inc. stock outperform value stocks2025 Performance Recap & Stepwise Trade Signal Implementation - ulpravda.ru
Lyra Therapeutics (NASDAQ:LYRA) Trading Up 0.3% – Time to Buy? - Defense World
LYRA (Lyra Therapeutics) EV-to-OCF : -0.46 (As of Dec. 22, 2025) - GuruFocus
Can Lyra Therapeutics Inc. stock surprise with earnings upside2025 Historical Comparison & Free AI Powered Buy and Sell Recommendations - Bölüm Sonu Canavarı
Is Lyra Therapeutics Inc. stock a buy for dividend growthJuly 2025 Movers & Low Risk High Win Rate Stock Picks - Улправда
Lyra Therapeutics Earnings Notes - Trefis
Take Profit: Will Lyra Therapeutics Inc. stock outperform value stocksPortfolio Performance Report & Expert Curated Trade Setup Alerts - Улправда
Why Lyra Therapeutics Inc. stock remains on buy listsJuly 2025 WrapUp & Weekly High Momentum Picks - Улправда
Insmed drops as it abandons brensocatib in rhinosinusitis - Seeking Alpha
Lyra Therapeutics Stock Rockets 56% With 6-Day Winning Streak - Trefis
Will Lyra Therapeutics Inc. stock pay special dividends2025 Trade Ideas & High Conviction Investment Ideas - Newser
Lyra Therapeutics (LYRA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why Lyra Therapeutics Inc. stock is popular among millennials2025 Investor Takeaways & Expert Approved Momentum Ideas - Newser
Will Lyra Therapeutics Inc. stock benefit from infrastructure spendingQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - Newser
Published on: 2025-11-27 15:46:05 - moha.gov.vn
PERCEPTIVE ADVISORS LLC Reduces Stake in Lyra Therapeutics Inc - GuruFocus
Will Product Innovation Drive Hisar Spinning Mills Limited Stock in YEARRisk Management Strategies & Free Extraordinary Earning Power - earlytimes.in
Will Lyra Therapeutics Inc. stock deliver shareholder valueMarket Growth Summary & High Accuracy Trade Signal Alerts - newser.com
Can Lyra Therapeutics Inc. stock deliver sustainable ROEBull Run & Consistent Return Strategy Ideas - newser.com
What technical charts say about Lyra Therapeutics Inc. stockVolume Spike & Weekly Watchlist for Hot Stocks - newser.com
How to interpret RSI for Lyra Therapeutics Inc. stock2025 Short Interest & Stepwise Trade Signal Guides - newser.com
Lyra Therapeutics Inc (LYRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lyra Therapeutics Inc 주식 (LYRA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Palasis Maria | President & CEO |
Jan 06 '26 |
Sale |
3.36 |
1,702 |
5,726 |
1,096,733 |
4.73%
0.92%
자본화:
|
볼륨(24시간):